Stock Track | REMEGEN Soars 8.86% Amid Broader Biotech Rally in Hong Kong

Stock Track
Aug 29

REMEGEN (09995) experienced a significant surge in its stock price, soaring 8.86% during Friday's trading session in Hong Kong. This impressive gain comes as part of a broader rally in the biotech sector, with several companies in the industry posting substantial increases.

The biotech sector in Hong Kong saw widespread gains, with companies like Cutia Therapeutics leading the pack with a 14% increase. Other notable performers included Antengene (up 13%), HBM Holdings and TransThera Sciences (both up 9%), and CARsgen Therapeutics (up 7%). REMEGEN's 8.86% rise positioned it firmly among the top performers in this sector-wide upswing, reflecting strong investor confidence in the biotech industry and REMEGEN's potential within it.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10